The Health Care Authority’s recently approved second quarter preferred drug list is now available.
Also in Washington, the Pharmacy and Therapeutics (P&T) Committee and Drug Utilization Review (DUR) Board meeting is scheduled for June 15, 2022, to review drug classes for the Washington PDL (Preferred Drug List), and the drug classes for the Apple Health (Medicaid) PDL. This meeting will be held by Zoom online seminar only and you will need to register in advance to receive the meeting link.
For more information, contact NACDS’ Mary Staples at 817-442-1155.